Food and Drug Law Institute's Conference on Post Market Safety Survellience

PHILADELPHIA - December 9, 2004 - Anapol Schwartz Weiss Cohan Feldman and Smalley, P.C. (Anapol Schwartz) attorney Sol H. Weiss lectured at the Food and Drug Law Institute's Conference on Post Market Safety Survellience.  The program took place on November 18, 2004 in Washington, D.C. and discussed the changes at the Food and Drug Administration in light of recent recalls and a more meaninful signal detection for approvals.

Mr. Weiss, a shareholder with Anapol Schwartz, concentrates his practice in complex civil litigation including class actions and pharmaceutical cases, medical and other professional malpractice, securities litigation and products liability matters.  He earned his bachelor's degree from the Pennsylvania State University in 1968 and his law degree from Villanova University School of Law in 1972.  He is licensed to practice in Pennsylvania as well as being specially admitted to practice in other states.

Serving in various positions for the Pennsylvania Trial Lawyers Association, Mr. Weiss was also a member of the Board of the Philadelphia Trial Lawyers Association.  He currently serves as President of the Eastern Chapter of the American Board of Trial Advocates.  He is a frequent lecturer on class actions, pharmaceutical liability, civil litigation issues, trial skills and technology in the courtroom.  He has lectured for many professional groups including the Pennsylvania Bar Institute, Mealey's , the Philadelphia Trial Lawyers Association and for private industry.  He is a member of the American, Pennsylvania and Philadelphia Bar Associations as well as the American, Pennsylvania and Philadelphia Trial Lawyers Associations.  He is also a member of the Public Investors Arbitration Bar Association, which exclusively represents investors in stock fraud and loss caes.

Mr. Weiss is an active member of the Board of Consultors of the Villanova University School of Law.  He has also served as a Director of the Linda Creed Breast Cancer Foundation.